Articles tagged with Depression
Researchers have found that improved learning processes are associated with reduced symptoms of depression. By using brain imaging and mathematical modeling, the team identified distinct paths to depression symptoms and proposed a new approach for treating clinical depression.
New research at Penn State found that close, supportive relationships with parents, especially dads, can help stave off certain adjustment problems during adolescence. The study showed that father-adolescent intimacy was associated with fewer depressive symptoms and weight concerns across most of adolescence.
A new study found that 28.4% of adults with a history of suicide attempts are psychologically flourishing, achieving excellent mental health with factors like social support, higher income, and absence of chronic pain contributing to their well-being
A University of Otago study found that women with postpartum depression experience different intensity and hedonic perception of smells compared to healthy women. The research adds evidence to the argument that postpartum depression should be studied separately from major depression.
A new score, PROPr, assesses health-related quality of life in patients with kidney failure by considering cognitive function, depression, fatigue, and social roles. The study's findings support the validity of PROPr among patients undergoing hemodialysis or kidney transplants.
A randomized clinical trial found that physical exercise was significantly more effective in improving depressive symptoms among older adults with mild to moderate depression, compared to antidepressant treatment. Adverse side effects were more common in the medication group.
Research suggests that antidepressant treatment can improve outcomes for individuals with comorbid diabetes and depression, reducing the risk of serious complications such as heart disease. Regular adherence to antidepressants is associated with better diabetes management and quality of life.
A recent study assessing the impact of the COVID-19 pandemic on mental health among individuals aged 50-80 in São Paulo, Brazil, found that the prevalence of depression and anxiety remained relatively stable. The study, which involved over 2,000 participants, revealed a decrease in symptoms of both conditions during the pandemic period.
A study by the University of Kansas reveals that parental substance use disorder is linked to neglectful behavior, but only when combined with mental health issues or lack of social support. The researchers suggest that treatment should consider these multiple factors to prevent child neglect and help families.
A new study published in The Lancet Psychiatry suggests that electroconvulsive therapy (ECT) is a medically safe mental health intervention for individuals with severe depression. The research, which analyzed over 10,000 patients, found no clinically significant increased risk of serious medical events with ECT exposure.
Low-intensity cognitive behavior therapy (CBT) has been found to be effective in reducing anxiety and depression during the COVID-19 pandemic. A new consumer guide aims to help people navigate the system and find targeted services.
Researchers developed a new approach that integrates brain lesion datasets with data on deep brain stimulation and transcranial magnetic stimulation to identify promising therapeutic targets. This method may help clarify the cause of neuropsychiatric conditions and relieve symptoms.
Research reveals that women with urinary incontinence are more likely to experience depression, lower self-worth, and poorer mental health outcomes. The study emphasizes the importance of discussing mental health with patients undergoing treatment.
A recent study by Yale researchers found that psilocybin increases the density of dendritic spines, aiding information transmission between neurons and potentially treating depression. Mice subjected to stress showed behavioral improvements after receiving psilocybin, suggesting a possible therapeutic effect.
A study published at ECCMID 2021 found that individuals with depression and schizophrenia have a higher incidence of TB. The research suggests that mental health may play a causal role in increasing TB risk, particularly through its effect on the immune system.
Researchers from University of Tsukuba used AI to detect signs of depression and predict psychological distress among workers. The study found that an AI system was more accurate than psychiatrists in detecting severe psychological distress.
LGBTQ youth experience daily stressors related to their multiple stigmatized identities, leading to greater negative emotions and associated mental health issues. The study found that minority stressors are associated with higher levels of negative affect on days when participants experienced more stressors.
A year-long Australian population study found full-time workers in poorly managed organisations have a threefold increased risk of being diagnosed with depression. Poor workplace mental health can be traced back to poor management practices and low resources.
A large-scale analysis of over 150,000 middle-aged people found that those with two or more physical health conditions were at greater risk of developing depression and anxiety. The study confirmed the importance of integrating mental health support into care plans for individuals with multiple physical health conditions.
A study of over 280,000 young adults found that cannabis use was associated with increased suicidal ideation, plan, and attempt, regardless of depression levels. Women were more likely to experience these outcomes than men.
A study by researchers from King's College London and IMIM found that 6.4% of Europeans suffer from depression, with higher rates in economically developed nations and varying rates across countries. The study suggests that demographic and socio-political factors contribute to the differences in prevalence.
A new study found that LGB Millennials experience worse health disparities than older peers, contradicting expectations. Health disadvantages persist throughout older generations and are even worsened by generational trends.
A 20-year longitudinal study confirms childhood depression is associated with higher levels of adult anxiety, substance use disorders, and worse health and social functioning. Children who received specialty mental health services showed improved outcomes, but still faced problems in other areas.
Research found increased screen time during COVID-19 pandemic correlated with higher anxiety scores and a rise in pandemic-related distress. Young adult students scored higher than non-students in mental health concerns, while no association was found between screen time use and depression.
A small feasibility study suggests that tai chi can significantly reduce symptoms of depression, anxiety, and stress in people who have had a stroke. The intervention improved sleep efficiency, reduced wakefulness after sleep onset, and decreased time awake.
A large study found that depression symptoms in fathers of premature infants persist after discharge from the NICU, affecting their ability to engage in positive parenting activities. The researchers emphasize the need for increased attention to mental health support for new fathers during this critical period.
A 10-week lifestyle modification programme improved cardiovascular and mental health in people living with obesity, with significant reductions in anxiety, depression, body weight, blood pressure, and cholesterol levels. The programme's personalized approach, non-judgemental environment, and focus on emotional eating triggers led to su...
Researchers found that omega-3 fatty acids can reduce depressive symptoms by preventing cell death and promoting neurogenesis. The study used a combination of laboratory and patient research to identify the molecular mechanisms involved in this relationship.
Researchers at UIC's Center for Alcohol Research in Epigenetics have discovered a key regulator of gene expression and anhedonia during alcohol withdrawal. Blocking STAT3 activity alleviates withdrawal-induced depression in rats, and similar results are seen in human postmortem hippocampus samples of individuals with alcohol use disorder.
Research at the Max Planck Institute found that people over 50 with multiple health risks are more likely to experience depression. However, the severity of depressive moods decreases with age, suggesting a potential psychological component and better coping mechanisms in older adults.
A new study found that a one-hour inhalation session with 25% nitrous oxide gas improved depression symptoms for over two weeks, with fewer adverse side effects compared to higher concentrations. The effects were nearly as effective as 50% nitrous oxide at rapidly relieving symptoms of treatment-resistant depression.
A single treatment involving breathing in a mixture of oxygen and nitrous oxide significantly improved symptoms in people with treatment-resistant depression. Symptoms of depression improved rapidly following treatment, with benefits lasting for several weeks.
A phase 2 trial found that a single one-hour treatment with nitrous oxide can relieve symptoms of treatment-resistant depression for several weeks. The study showed significant improvements in depression symptoms, with a four-fold lower risk of adverse effects at lower concentrations.
Researchers found a novel biomarker indicating resilience to chronic stress in the brain, which is largely absent in people suffering from major depressive disorder. This absence is associated with pessimism in daily life and reduced adaptive responses to stress.
Research reveals a strong link between hyperhomocysteinemia and migraine with aura in rats, showing elevated HCY levels increase susceptibility to cortical spreading depression. The study suggests timely correction of high homocysteine levels may be beneficial for treating migraine-related symptoms.
A systematic review of treatments for depression in people with coronary heart disease suggests that exercise is the most effective short-term treatment. The study also found that combination treatments, including antidepressants and psychotherapy, had stronger effects than other interventions.
A recent study used cell phone apps, wearables, brain activity, and lifestyle factors to generate individualized predictions of depression. The results could lead to tailored treatment plans for mental health, moving beyond one-size-fits-all approaches.
Researchers have developed a deep-learning model that can track changes in speech coordination features to detect depression. The app aims to provide early intervention before severe depression sets in, potentially saving lives.
A new study published in Molecular Psychiatry found that people whose sleep pattern goes against their natural body clock are more likely to have depression and lower levels of wellbeing. Being genetically programmed to be an early riser is protective against major depression, and improves wellbeing.
Postpartum women in bad romantic relationships are more likely to suffer symptoms of depression and have lower heart rate variability (HRV), which can impact long-term wellness and mortality. Research shows a clear link between relationship quality during pregnancy and postpartum depression and HRV.
A new meta-analysis of 215 COVID-19 studies reveals a wide range of ways the virus affects mental health and brain function. Common symptoms include fatigue, loss of smell, depression, anxiety, and headaches, even in mild cases, suggesting that mental health impacts may be more prevalent than expected.
During the COVID-19 pandemic, many ECT centers reduced services, but most were able to react and return to care by mid-summer. The survey found that 70% of sites had patients return to inpatient psychiatric care due to unscheduled ECT cancellations.
A large genetic study suggests that going to bed earlier may be associated with a lower risk of major depression. The study found that one-hour earlier sleep timing corresponded to a 23% lower likelihood of having a major depressive disorder. Further research is needed to understand the mechanisms behind this effect and how shifting sl...
A large-scale genetic analysis of depression identified 178 loci and 223 single-nucleotide polymorphisms associated with increased depression risk. The study, involving over 1.2 million participants, provides new insights into the biological basis of depression and potential drug repurposing.
Researchers from Synapsy have identified lactate's key features, including NADH and neurogenesis, which contribute to its antidepressant effect. Lactate restores adult neurogenesis in the hippocampus, a region crucial for memory and depression.
A new study has identified 178 gene variants linked to major depression, providing insights into the disorder's genetic complexity and potential treatments. The findings may help identify individuals most at risk of depression and inform personalized treatment approaches.
Researchers from iPSYCH have identified 33 new genetic variants associated with bipolar disorder, more than doubling the number of known genetic risk factors. These variants play a role in brain functions and signalling between nerve cells, providing potential ideas for new treatments.
A study published in BJPsych Open found that women with depression during pregnancy or a history of depression had reduced quality of mother-infant interactions. Despite this, all mothers and their babies improved over time, indicating potential for future attunement.
A new study from Rice University found that widowed spouses with higher levels of bodily inflammation experienced more severe symptoms of depression three months later. The researchers identified a potential biomarker to predict who is at greatest risk for long-term repercussions of loss.
A NYITCOM researcher has secured a $1.6 million NIH grant to study the role of brain cells called astrocytes in regulating dopamine signaling. The study aims to identify new therapeutic treatments for clinical depression, which affects over 260 million people worldwide.
A network meta-analysis of 58 randomized controlled trials involving 9,301 patients found that psychotherapy and pharmacotherapy were significantly more effective than care-as-usual or waitlist control. Combined treatment, particularly cognitive behavioral therapy, was better than either treatment alone.
A new study found that almost half of women with babies under six months old met the threshold for postnatal depression during the first COVID-19 lockdown. Social isolation and lack of support were significant contributors to this increased risk.
After cognitive behavioral therapy, serotonin transporter levels increased in individuals recovering from depression. This finding suggests that the serotonin system may play a role in protecting against depression, rather than causing it.
Researchers found a significant association between COVID-19-related income loss and financial strain with depressive symptoms, independent of anxiety. Participants who experienced a decrease in income over the study period reported an increase in depressive symptoms.
A study by the University of Ottawa found nearly two-thirds of Black individuals in Canada suffer from severe depressive symptoms. Women are disproportionately affected, with those who experience racial discrimination also showing higher rates.
A new neuroimaging technique using diffuse optical tomography studied brain stimulation for depression, finding reduced brain activation in response to rTMS. The study suggests that treatment parameters may need adjusting for patients with severe depression.
Patients with implantable cardioverter defibrillators (ICDs) are at risk of developing anxiety and depression after implantation, according to a new study. Regular screening is necessary to identify patients who may benefit from additional support.
A study by University of Surrey found that frequent internet use among older adults (55-75) was beneficial for mental health and quality of life under lockdown. Those who used the internet more frequently, particularly for communication, had lower depression scores and an enhanced quality of life.
Researchers at UZH found that increased sensitivity in a specific brain region contributes to anxiety and depression in response to stress. The study establishes an objective neurobiological measure for stress resilience in humans, which may aid in selecting professions or developing stress resilience training.
In a small study, psilocybin, the active compound in magic mushrooms, was found to be at least as effective as a leading antidepressant medication in reducing depressive symptoms. The results showed that depression scores decreased more quickly and were greater in magnitude in the psilocybin group compared to the escitalopram group.